Preset Insider Trade Ideas Penny Stock Buys Insider Trading All Insider Purchases All Insider Sales All Insider Purchases Above 25K Officer Sales Above 25K CEO/CFO Sales Above 25K Insider Purchases Today Insider Purchases Past Week Insider Purchases Past Month Officer Purchases Today Officer Purchases Past Week Officer Purchases Past Month Officer Purchases Past Week Officer Purchases Past Month Insider Sales Today Insider Sales Past Week Insider Sales Past Month Officer Sales Today Officer Sales Past Week
KKR Group Co. Inc.'s Net Worth $0
Estimate Recalculated Dec 3, 2025 08:06PM EST
Who is KKR Group Co. Inc. KKR Group Co. Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BrightSpring Health Services, Inc., KKR Real Estate Select Trust Inc., KKR Real Estate Finance Trust Inc., Transphorm, Inc., KKR FS Income Trust, Crescent Energy Co, AppLovin Corp, KnowBe4, Inc., LAUREATE EDUCATION, INC., US Foods Holding Corp., KKR FS Income Trust Select, BrightView Holdings, Inc., and OneStream, Inc..
SEC CIK KKR Group Co. Inc.'s CIK is 0001932162
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BrightSpring Health Services, Inc. Investor
Updated Sep 13, 2024
KKR Real Estate Select Trust Inc. Investor
Updated Nov 04, 2024
KKR Real Estate Finance Trust Inc. Investor
Updated Jun 09, 2022
KKR FS Income Trust Investor
Updated Jul 05, 2023
Crescent Energy Co Investor
Updated Apr 03, 2024
LAUREATE EDUCATION, INC. Investor
Updated Nov 22, 2022
US Foods Holding Corp. Investor
Updated Mar 09, 2023
KKR FS Income Trust Select Investor
Updated Mar 28, 2024
BrightView Holdings, Inc. Investor
Updated May 28, 2024
BridgeBio Pharma, Inc. Investor
Updated Sep 17, 2024